BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 27228163)

  • 1. CD14 Is a Co-Receptor for TLR4 in the S100A9-Induced Pro-Inflammatory Response in Monocytes.
    He Z; Riva M; Björk P; Swärd K; Mörgelin M; Leanderson T; Ivars F
    PLoS One; 2016; 11(5):e0156377. PubMed ID: 27228163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD14 and TLR4 mediate cytokine release promoted by electronegative LDL in monocytes.
    Estruch M; Bancells C; Beloki L; Sanchez-Quesada JL; Ordóñez-Llanos J; Benitez S
    Atherosclerosis; 2013 Aug; 229(2):356-62. PubMed ID: 23880187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-CD14 antibody reduces LPS responsiveness via TLR4 internalization in human monocytes.
    Kim D; Kim JY
    Mol Immunol; 2014 Feb; 57(2):210-5. PubMed ID: 24172224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine secreted by S100A9 via TLR4 in monocytes delays neutrophil apoptosis by inhibition of caspase 9/3 pathway.
    Lee NR; Park BS; Kim SY; Gu A; Kim DH; Lee JS; Kim IS
    Cytokine; 2016 Oct; 86():53-63. PubMed ID: 27459393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S100a8/a9 released by CD11b+Gr1+ neutrophils activates cardiac fibroblasts to initiate angiotensin II-Induced cardiac inflammation and injury.
    Wu Y; Li Y; Zhang C; A X; Wang Y; Cui W; Li H; Du J
    Hypertension; 2014 Jun; 63(6):1241-50. PubMed ID: 24711518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoinhibitory regulation of S100A8/S100A9 alarmin activity locally restricts sterile inflammation.
    Vogl T; Stratis A; Wixler V; Völler T; Thurainayagam S; Jorch SK; Zenker S; Dreiling A; Chakraborty D; Fröhling M; Paruzel P; Wehmeyer C; Hermann S; Papantonopoulou O; Geyer C; Loser K; Schäfers M; Ludwig S; Stoll M; Leanderson T; Schultze JL; König S; Pap T; Roth J
    J Clin Invest; 2018 May; 128(5):1852-1866. PubMed ID: 29611822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of nuclear factor-κB responses by the S100A9 protein is Toll-like receptor-4-dependent.
    Riva M; Källberg E; Björk P; Hancz D; Vogl T; Roth J; Ivars F; Leanderson T
    Immunology; 2012 Oct; 137(2):172-82. PubMed ID: 22804476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptor 4 mediates the antitumor host response induced by a 55-kilodalton protein isolated from Aeginetia indica L., a parasitic plant.
    Okamoto M; Oh-E G; Oshikawa T; Furuichi S; Tano T; Ahmed SU; Akashi S; Miyake K; Takeuchi O; Akira S; Himeno K; Sato M; Ohkubo S
    Clin Diagn Lab Immunol; 2004 May; 11(3):483-95. PubMed ID: 15138173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The roles of toll-like receptor 4, CD33, CD68, CD69, or CD147/EMMPRIN for monocyte activation by the DAMP S100A8/S100A9.
    Möller A; Jauch-Speer SL; Gandhi S; Vogl T; Roth J; Fehler O
    Front Immunol; 2023; 14():1110185. PubMed ID: 37056775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S100A9 induces differentiation of acute myeloid leukemia cells through TLR4.
    Laouedj M; Tardif MR; Gil L; Raquil MA; Lachhab A; Pelletier M; Tessier PA; Barabé F
    Blood; 2017 Apr; 129(14):1980-1990. PubMed ID: 28137827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD14 dependence of TLR4 endocytosis and TRIF signaling displays ligand specificity and is dissociable in endotoxin tolerance.
    Rajaiah R; Perkins DJ; Ireland DD; Vogel SN
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8391-6. PubMed ID: 26106158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S100A9-induced release of interleukin (IL)-6 and IL-8 through toll-like receptor 4 (TLR4) in human periodontal ligament cells.
    Gao H; Zhang X; Zheng Y; Peng L; Hou J; Meng H
    Mol Immunol; 2015 Oct; 67(2 Pt B):223-32. PubMed ID: 26038301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DAMP molecule S100A9 acts as a molecular pattern to enhance inflammation during influenza A virus infection: role of DDX21-TRIF-TLR4-MyD88 pathway.
    Tsai SY; Segovia JA; Chang TH; Morris IR; Berton MT; Tessier PA; Tardif MR; Cesaro A; Bose S
    PLoS Pathog; 2014 Jan; 10(1):e1003848. PubMed ID: 24391503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloid related proteins activate Toll-like receptor 4 in human acute coronary syndromes.
    Yonekawa K; Neidhart M; Altwegg LA; Wyss CA; Corti R; Vogl T; Grigorian M; Gay S; Lüscher TF; Maier W
    Atherosclerosis; 2011 Oct; 218(2):486-92. PubMed ID: 21782178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation of LPS-induced inflammation by ICT, a derivate of icariin, via inhibition of the CD14/TLR4 signaling pathway in human monocytes.
    Wu J; Zhou J; Chen X; Fortenbery N; Eksioglu EA; Wei S; Dong J
    Int Immunopharmacol; 2012 Jan; 12(1):74-9. PubMed ID: 22056950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane-anchored CD14 is required for LPS-induced TLR4 endocytosis in TLR4/MD-2/CD14 overexpressing CHO cells.
    Shuto T; Kato K; Mori Y; Viriyakosol S; Oba M; Furuta T; Okiyoneda T; Arima H; Suico MA; Kai H
    Biochem Biophys Res Commun; 2005 Dec; 338(3):1402-9. PubMed ID: 16263085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An inflammation loop orchestrated by S100A9 and calprotectin is critical for development of arthritis.
    Cesaro A; Anceriz N; Plante A; Pagé N; Tardif MR; Tessier PA
    PLoS One; 2012; 7(9):e45478. PubMed ID: 23029038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of Toll-like receptor (TLR)2 and TLR4 on CD14dimCD16+ monocytes in response to sepsis-related antigens.
    Skinner NA; MacIsaac CM; Hamilton JA; Visvanathan K
    Clin Exp Immunol; 2005 Aug; 141(2):270-8. PubMed ID: 15996191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S100A9 induced inflammatory responses are mediated by distinct damage associated molecular patterns (DAMP) receptors in vitro and in vivo.
    Chen B; Miller AL; Rebelatto M; Brewah Y; Rowe DC; Clarke L; Czapiga M; Rosenthal K; Imamichi T; Chen Y; Chang CS; Chowdhury PS; Naiman B; Wang Y; Yang D; Humbles AA; Herbst R; Sims GP
    PLoS One; 2015; 10(2):e0115828. PubMed ID: 25706559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eritoran inhibits S100A8-mediated TLR4/MD-2 activation and tumor growth by changing the immune microenvironment.
    Deguchi A; Tomita T; Ohto U; Takemura K; Kitao A; Akashi-Takamura S; Miyake K; Maru Y
    Oncogene; 2016 Mar; 35(11):1445-56. PubMed ID: 26165843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.